Container Closure Integrity Testing Market, By Material, By Technology, By Packaging Type, By Service Type, By End-user, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Container Closure Integrity Testing Market size was valued at US$ 280.1 Million in 2025, expanding to a CAGR of 10.2% from 2026 to 2033.

The Container Closure Integrity Testing (CCIT) market comprises instruments, testing technologies, and validation services used to verify the integrity of pharmaceutical and biopharmaceutical packaging, ensuring sterile products remain free from leaks and contamination throughout their shelf life. Market growth is driven by stricter regulatory requirements, increasing production of injectable drugs and biologics, and a stronger focus on product quality and patient safety. Rising adoption of deterministic, non-destructive testing methods, automation, and advanced inspection systems is further accelerating demand. However, high equipment costs and complex validation requirements continue to limit broader market adoption.

Container Closure Integrity Testing Market- Market Dynamics

Rising Production of Sterile Injectable Drugs and Biologics

A large factor behind the growth of the CCIT Market is the rise in producing sterile injectable drugs, biologics, vaccines and advanced therapeutics. With the development of more sterile parenteral products, pharmacies are becoming increasingly mindful and diligent in ensuring container closure integrity for their products throughout each phase of their life cycle, to maintain sterility and prevent contamination with microbes or moisture from entering. Agencies like the U.S. Food and Drug Administration (FDA) and the United States Pharmacopeia (USP <1207>) have regulatory requirements for container closure integrity testing of sterile products. The result is a rapidly growing market for deterministic methods of CCIT. Global companies are currently manufacturing over 80 brands of CCIT technology and over 40 services specific to CCIT. The ongoing growth of biologics, prefilled syringes, drug injection therapies and more stringent regulations will continue to place an increased demand for advanced container closure integrity testing solutions.

Container Closure Integrity Testing Market- Segmentation Analysis:

The worldwide market is segmented based on Material, Technology, Packaging Type, Service Type, End-user, Application, and Region.

Vial's product type was most often used for drug formulations that required strict assurance, including sterile injectable drugs, vaccines and biologics and lyophilized products. Pharmaceutical manufacturers rely on glass and polymer vials for their drug formulation because they have a high degree of packaging integrity that can provide complete validation of the sterility requirement in both the storage and distribution process. Because of the increased regulatory requirements, such as those imposed by the FDA, EMA and USP Section 1207, there is an increased demand for robust integrity testing of vial packaging systems. The continuing increase in production of injectable therapy, biosimilar and oncology drugs is creating a robust demand for vial-based packaging. The same product type is expected to maintain its dominant position in the market because of widespread use of deterministic testing technologies such as vacuum decay and high-voltage leak detection (HVLD).

The Contract Development and Manufacturing Organizations (CDMOs) segment represents the largest opportunity for the container closure integrity testing (CCIT) market, driven by the growing outsourcing of pharmaceutical and biopharmaceutical manufacturing. As CDMOs expand production of sterile injectables, biologics, cell therapies, and gene therapies, the need to ensure packaging integrity for vials, syringes, cartridges, and other drug delivery systems continues to rise. Increasing regulatory scrutiny and quality assurance requirements are further accelerating the adoption of advanced CCIT technologies across CDMO facilities.

Container Closure Integrity Testing Market- Geographical Insights

The Container Closure Integrity Testing (CCIT) Market in North America has been characterized by its traditional strength of having an advanced pharmaceutical manufacturing infrastructure, sophisticated biologics production, an extensive network of established drug manufacturing facilities, and rigorous regulatory requirements related to the packaging of sterile drugs. The US has led the way in promoting the increased use of USP <1207> deterministic testing methods and injecting significant amounts into the development of injectable drugs.

For example, in 2025, the US Food and Drug Administration (FDA) issued approvals for 50 new products from a variety of companies, and many of these new drugs require packaging that is validated as sterile and undergo CCIT during product development and commercialization. The US FDA maintains an extensive network of registered drug manufacturing facilities supplying North America with pharmaceutical products at all stages of the CCIT manufacturing process. This has created continuous demand for CCIT products in the North American market, especially in pharmaceuticals, biotechnology, and contract manufacturers.

United States Container Closure Integrity Testing Market- Country Insights

The US represents the single greatest USCCIT market due to its significant investment in pharmaceutical R&D, manufacturing biologics and the FDA's regulation of sterile products. The increasing number of drugs in the pipeline for injectable delivery systems, biologics and advanced technologies continue to increase the need for reliable package integrity testing. In 2025, for example, the FDA reported the approval of 50 new drugs, but over half of them (52%) were for very few patients; so, many of the new injectable drugs must have validated sterile packaging systems that undergo rigorous container closure integrity validation. The anticipated continuation of US manufacturers investing in drug manufacturing and biologics production will continue to boost the market for advanced deterministic CCIT products.

Container Closure Integrity Testing Market- Competitive Landscape:

The Container Closure Integrity Testing (CCIT) market - competitive landscape is very competitive, as companies have made significant investments into technological innovation, meeting regulatory compliance and producing high-quality, highly-precise testing solutions for pharmaceutical and biotechnology industries. Companies compete based on accuracy of the tests they provide to customers, degree of automation of their products, and support capabilities (for both deterministic & non-destructive inspection).

Companies in the CCIT market frequently employ a variety of strategic initiatives to grow their market share and respond to the evolving needs of this industry through R&D investment, product introductions, and partnerships, as well as expansion into new markets globally. Examples of major players in the CCIT market that are utilizing cutting edge technology along with their global expertise include West Pharmaceutical Services, Inc., INFICON Holding AG, SP Scientific, Uson, L.P., and Shimadzu Corporation. These companies are utilizing leading edge technology to enhance their competitiveness and respond to the growing demands for quality assurance in the marketplace.

Recent Developments:

In May 2026, CS Analytical announced that its enhanced package distribution testing services have now completed their buildout and are fully operational. The enhancements are the result of a significant investment in state-of-the-art ASTM D4169-23 and ISTA testing capabilities, which will include a customized multimodal vibration/temperature/altitude simulation platform for validating packaging of pharmaceutical and medical device products.

In January 2026, Sharp Services disclosed that they are investing over €20 million for expanding their packaging capacity for injectables at their locations in both the Netherlands and Belgium. The new investment will include cold-chain storage, syringe assembly, blister packaging, and GMP production to accommodate the growing demand for injectable drug formats.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Albany Molecular Research Inc. (AMRI)
• Analytical Lab Group
• Berkshire Sterile Manufacturing
• Confarma
• Cormica
• Curia
• DDL and Nelson Labs
• Eurofins Scientific
• Gateway Analytical
• Genesis Packaging Technologies
• Labcorp Drug Development
• Lighthouse Instruments
• Mocon, Inc.
• Nelson Labs
• Pfeiffer Vacuum
• PTI (Packaging Technologies & Inspection)
• Qualitest
• SGS SA
• Stevanato Group
• Toxikon Corporation
• West Pharmaceutical Services
• WIL Research Laboratories
• Wilco
• Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY MATERIAL- MARKET ANALYSIS, 2020 - 2033

• Glass
• Plastic/Polymer
• Elastomer/Rubber Closures
• Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

• Vacuum Decay (Non-destructive)
• Helium Leak Detection
• High Voltage Leak Detection (HVLD)
• Laser-Based Headspace Analysis
• Dye Ingress
• Microbial Ingress
• Ultrasound Detection
• Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY PACKAGING TYPE- MARKET ANALYSIS, 2020 - 2033

• Vials
• Pre-filled Syringes
• Ampoules
• Cartridges
• IV Bags and Pouches
• Blister Packs
• Bottles
• Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2020 - 2033

• Method Development & Validation
• Routine Integrity Testing
• Stability Testing Support
• Regulatory Compliance Consulting
• Failure Investigations

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

• Sterile Product Testing
• Lyophilized Product Testing
• Liquid Drug Product Testing
• Combination Product Testing

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs)
• Medical Device Companies
• Academic & Research Institutes

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA